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Abstract
Lectins and adhesins are involved in bacterial adhesion to host tissues and mucus during early steps of infection. We report
the characterization of BC2L-C, a soluble lectin from the opportunistic pathogen Burkholderia cenocepacia, which has two
distinct domains with unique specificities and biological activities. The N-terminal domain is a novel TNF-a-like fucose-
binding lectin, while the C-terminal part is similar to a superfamily of calcium-dependent bacterial lectins. The C-terminal
domain displays specificity for mannose and L-glycero-D-manno-heptose. BC2L-C is therefore a superlectin that binds
independently to mannose/heptose glycoconjugates and fucosylated human histo-blood group epitopes. The apo form of
the C-terminal domain crystallized as a dimer, and calcium and mannose could be docked in the binding site. The whole
lectin is hexameric and the overall structure, determined by electron microscopy and small angle X-ray scattering, reveals a
flexible arrangement of three mannose/heptose-specific dimers flanked by two fucose-specific TNF-a-like trimers. We
propose that BC2L-C binds to the bacterial surface in a mannose/heptose-dependent manner via the C-terminal domain.
The TNF-a-like domain triggers IL-8 production in cultured airway epithelial cells in a carbohydrate-independent manner,
and is therefore proposed to play a role in the dysregulated proinflammatory response observed in B. cenocepacia lung
infections. The unique architecture of this newly recognized superlectin correlates with multiple functions including
bacterial cell cross-linking, adhesion to human epithelia, and stimulation of inflammation.
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Introduction
The Burkholderia cepacia complex (Bcc) is a group of Gram-
negative bacteria comprising at least 17 species [1]. Bcc species are
common in the environment and can be isolated from various
sources including water, soil and vegetation. Bcc bacteria are
involved in symbiosis and other interactions with plants that are
beneficial for agriculture, but they are also recognised as important
opportunistic human pathogens. In particular, B. cenocepacia causes
infections in patients suffering from chronic granulomatous
diseases [2] and cystic fibrosis [3] with significant morbidity and
mortality. This is in part due to the extreme resistance of B.
cenocepacia strains to almost all clinically useful antibiotics and their
transmissibility between patients [4]. B. cenocepacia isolates survive
either extracellularly in the airways or intracellularly within
epithelial and phagocytic cells [5].
Among the virulence factors of B. cenocepacia [6], soluble lectins
bind to carbohydrates present on epithelial cells and mucus [7]. A
family of four soluble lectins has been identified in B. cenocepacia, all
of them containing at least one domain with strong sequence
similarity with LecB (PA-IIL) from Pseudomonas aeruginosa. LecB is a
tetrameric fucose-binding lectin with unusually high affinity for
carbohydrate mediated by two bridging calcium ions in its binding
site [8]. Its structure has been elucidated and the involvement in
biofilm formation and epithelial cell adhesion has been demon-
strated [9,10].
The four soluble lectins of B. cenocepacia are designated BC2L-A,
-B, -C and –D. BC2L-A, consisting of one LecB like domain,
associates as a dimer and binds mannose and oligomannose-type
N-glycans [7,11]. The three other lectins have additional N-
terminal domains. The N-terminal domain of BC2L-C has been
recently characterized as a novel fucose binding domain with a
PLoS Pathogens | www.plospathogens.org 1 September 2011 | Volume 7 | Issue 9 | e1002238TNF-a-like fold [12]. Thus, BC2L-C encompasses two lectin
domains probably assembling as oligomers, but nothing is known
about its architecture and biological role.
Here, we characterize the structure and specificity of the C-
terminal domain of BC2L-C. We also compare the specificity of
the whole lectin with that of each domain. The overall hexameric
architecture of the lectin was determined in solution by electron
microscopy and SAXS. Finally, we determined that this lectin
binds to the bacterial cell surface and elicits a proinflammatory
response in cultured respiratory epithelial cell cultures. Together,
we conclude that BC2L-C is a novel superlectin with multiple
specificities and biological functions.
Results
BC2L-C consists of two distinct lectin domains
BC2L-C has an N-terminal region of 155 amino acids (the
TNF-a-like lectin), a 28-aa linker region, and a 115-aa C-terminal
region (Fig. 1A) [12]. The C-terminal domain has sequence
similarity with two-calcium bacterial lectins such as LecB/PA-IIL
from P. aeruginosa (43% identity) and related ones (Fig. 1B). The
Ala-Ala-Asn sequence in the ‘‘specificity loop’’ [13] suggests that
this domain is specific for mannose.
BC2L-C interacts strongly with surfaces modified by mannose
and fucose residues but not by galactose, as shown by Surface
Plasmon Resonance (SPR) experiments, while the C-terminal
domain, BC2L-C-ct binds only to mannose-coated chips (Fig. 2).
Since the isolated BC2L-C-nt domain binds strongly to fucose but
not to mannose and galactose [12], BC2L-C is therefore a novel
type of lectin consisting of independent fucose and mannose-
binding domains.
The fine specificity of BC2L-C was determined using the
Glycan Array facility of Consortium for Functional Glycomics
with 377 carbohydrates available. BC2L-C bound to oligosaccha-
rides containing terminal mannose or fucose residues (Fig. 3A). In
contrast, the glycans bound by BC2L-C-ct included oligoman-
Author Summary
The glycoconjugates that cover the surface of eukaryotic
cells are a target for pathogens that use protein receptors
for binding to the carbohydrate moieties exposed.
Opportunistic bacteria such as Pseudomonas aeruginosa
and Burkholderia species of the B. cepacia complex display
a wide range of adhesins and soluble lectins that are
specific for human oligosaccharides. We characterized the
complex architecture of one Burkholderia cenocepacia
soluble lectin, and analysed the specificity of two different
lectin subdomains. We propose that one of the subdo-
mains attaches to sugars present on the bacteria surface,
enabling bacterial aggregation in microcolonies. The other
subdomain attaches to sugars in human airways. In
addition, this domain can elicit an inflammatory response
in airways cells. Burkholderia cenocepacia causes lethal
infections in cystic fibrosis patients and soluble lectins may
be novel therapeutics targets.
Figure 1. Sequence information. A) Peptide sequence of Bc2L-C with N-terminal domain in black, linker in green and C-terminal domain in red. B)
Sequence alignment of the C-terminal domain of BC2L-C with related lectins from Burkholderia cenocepacia, Pseudomonas aeruginosa, Ralstonia
solanacearum and Chromobacterium violaceum. Grey shading indicates the conservation of amino acids (black for fully conserved). Amino acids
involved in calcium binding are indicated by diamonds. Amino acids predicted to form hydrogen bonds with the carbohydrate ligand are indicated
by dots.
doi:10.1371/journal.ppat.1002238.g001
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monosaccharide a-D-mannose (Man) was the shortest fragment
recognized, albeit not efficiently (#8 in Fig. 3B). The recognised
disaccharides were Mana1–2Man, Mana1–3Man and Mana1–
6Man indicating that the specificity for the linkage is not strict.
Hybrid structures with galactose or sialic acid on one antenna and
a-mannose on the other one were also bound. The BC2L-C-nt
domain is a fucosylated oligosaccharide binding lectin [12].
Therefore, bound fucosylated epitopes encompassed all fucosy-
lated human histo-blood group epitopes such as blood group O(H)
and Lewis oligosaccharides, with some preference for the Fuca1-
2Gal epitope (Fig. 3C). The specificity charts for the separated
domains do not overlap but their superimposition clearly explains
that the specificity of the whole protein is determined by the
contributions of the specificities of each domain.
The C-terminal domain of BC2L-C is a calcium-dependent
mannose/heptose binding lectin
The interaction of BC2L-C-ct with different carbohydrates was
characterised by isothermal titration microcalorimetry. All ther-
mograms display exothermic peaks with saturation of binding sites
at the end of titration (Fig. S1). Affinity values and thermody-
namics parameters are reported in Table 1. BC2L-C-ct bound to
Man and a-methyl-mannoside (aMeMan) with a strong affinity in
the micromolar range but with a stoichiometry close to 0.5,
indicating that only one binding site per dimer is accessible. Using
the whole protein, the same stoichiometry and affinity was
measured for mannoside, but not for Lewis Y, a fucosylated
oligosaccharide that binds to the other domain with a stochio-
metry of one (n=1). The branched trimannoside (Mana1-
3(Mana1-6)Man) exhibited an even lower stoichiometry
(n=0.22) demonstrating that the two terminal mannose residues
bind to two BC2L-C-ct dimers, as observed previously for BC2L-
A/trimannose interaction [11].
Binding was also tested towards L-glycero-D-manno-heptopyranose
(Hept) since this residue is similar to mannose differing only in an
additional hydroxymethyl group at C-6 and several Hept residues
are in the B. cenocepacia lipopolysaccharide (LPS) [14,15]. The
methylated monosaccharide (aMeHept) bound with an affinity of
150 mM and the a1-3 linked disaccharide bound with an affinity of
88 mM, indicating that heptose-containing LPS could be a
candidate substrate for BC2L-C-ct binding.
The crystal structure of BC2L-C-ct was solved at 1.9 A ˚
resolution (Table 2), demonstrating a nine-stranded antiparallel
b-sandwich fold that is similar to the two-calcium lectins
characterised in P. aeruginosa [16], Chromobacterium violaceum [17],
and Ralstonia solanacearum [18] (Fig. 4A). The dimeric association
displays close similarity to the lectin BC2L-A, described previously
[7,11]. In contrast to other crystal structures in this family, no
electron density for calcium ions and monosaccharide (D-mannose)
was found in the final model, presumably due to the presence of
citric acid in the crystallization buffer. Without the stabilizing
effect of the two calcium ions in the binding site, the acidic amino
acids that mediate their binding appear to point in all directions
(Fig. 4B). A sulphate ion was observed close to one of the two
binding sites, establishing hydrogen bonds with Gln241, His177
and two bridging water molecules.
Modelling the complex with aMeMan was possible since BC2L-
C-ct has strong sequence similarity to the other lectins of the family
(Fig. 1B), in particular with the R. solanacearum RS-IIL for which a
crystal structure with calcium and mannose is available [18]. The
modelled binding site was built by reorienting the amino acids side
chains and slightly modifying the conformations of the loops
(Fig. 4C). The main differencewiththe mannose-binding site of RS-
IILis thepresence ofHis177(Asn inall otherlectins). Intheabsence
of calcium, this histidine interacts with one sulphate ion but also
modifies the conformation of the C-terminus of the other chain.
Since the C-terminal carboxyl group has an essential role in binding
mannose and calcium in all the other similar lectins, the putative
destabilizing role of His177 could account for the observed non-
even stoichiometry of the dimer. Modeling the interaction between
BC2L-C-ct and aMeHept was achieved by extending the hydro-
xymethylgroupatC5ofmannoseina glycolyl one.Thebindingsite
can accommodate this bulky group with no steric hindrance and the
mode of binding of aMeHept displays the same hydrogen bond
network that is observed for mannose (Fig. 4D).
BC2L-C is a hexameric superlectin with dimeric and
trimeric subdomains and flexible linkers
The oligomeric state of BC2L-C and the C- and N-terminal
domains were analysed by size exclusion chromatography com-
bined with multi-angle laser light scattering (SEC-MALLS) and
refractometry (RI) (Fig. S2). BC2L-C-ct is dimeric in solution with a
molecular mass of 2261 kDa whereas BC2L-C-nt is trimeric with a
molecular mass of 4161 kDa (the expected monomeric masses are
12.4 kDa and 19.3 kDa, respectively). The SEC/MALLS profile of
the whole BC2L-C analysis indicates a hexamer in solution with a
molecular mass corresponding to 14564 kDa (the expected mass of
the monomeric form is 28.2 kDa). These results are consistent with
the crystallographic data of each domain; the dimeric C-terminal
Figure 2. SPR sensorgrams of BC2L-C and C-ter domain on different monosaccharide-activated surfaces. The whole lectin binds
efficiently to CM5 chips covered with PAA-fucose and PAA-mannose (left panel), while the isolated C-terminal domain has a strong specificity for
fucose (right panel). In both cases, control curves obtained with galactose-modified channels have been subtracted.
doi:10.1371/journal.ppat.1002238.g002
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terminal domain [12]. The overall shape of the hexamer in solution
was determined by small angle X-ray scattering (SAXS) and
validated by negative stain electron microscopy (EM). The Guinier
analysis (Fig. S3 and Table S1) suggests an Rg of ,5 nm with the
absence of severe aggregation effects that allowed for the ab initio
shape reconstruction to be performed using the idealized SAXS
curve. The refined ab initio envelope is elongated (max length
,160 A ˚) with a pseudo 3-fold axis in the long direction and three
bulges protruding from the middle of this long axis. (Fig. 5A).
Negative stain electron microscopy analysis validated the SAXS
results. Indeed, the three-dimensional reconstruction of BC2L-C at
20 A ˚ resolution(Fig. 5B and 5D) shows the same global shape as the
SAXS envelope (Fig. 5C). These complementary results confirmed
the size and overall shape of the molecule allowing manual fitting of
the domains using the combined EM and SAXS reconstructions as
the template.
Positioning two trimers of BC2L-C-nt on the large axial bulges
and three dimers of BC2L-C-ct on the equatorial ring-like envelop
fitted well within the envelope (Fig. 6). However, attempts to
mathematically optimize this model were partially successful
probably because of the absence of the linker moieties in the
model. By adding random chains for the missing linkers (6 chains
each 28 residues in length) an acceptable value of chi=3.5 could be
attained (Fig. S4). Distances between domain extremities were
checked in the final model, the maximum one being 50 A ˚, a value
that allow for the 28 amino acid linkers to fit. The positions of the
linkers are not presented as definitive as the entire complex appears
to be flexible, especially in the central part of the molecule. Our
results suggest that the low-resolution shape with the two trimers
separated along the long axis and three dimers in the middle is the
conformation adopted in solution under physiological conditions. A
general 3-fold axis is visible, passing by through the trimers and by
the center of the donut, but the symmetry is broken by the twisted
orientations of dimers. Since the linkers could not be located using
available methods, two possible architectures (mode I and mode II)
can be proposed for the BC2L-C hexamer (Fig. 6B). However, our
shape reconstruction indicates that mode I is more probable to
occur in solution as the mode II would generate more extended
structures of high conformational variability.
BC2L-C is immunogenic and located at the bacterial
surface
The expression of BC2L-C in B. cenocepacia J2315 was previously
demonstrated by classical proteomics [12]. Western blots were
performed with the purified recombinant lectins BC2L-A, -B and -
C using rabbit antisera prepared against formalin-fixed intact B.
cenocepacia K56-2 cells (clonally related to J2315). The purified
recombinant lectins BC2L-B and -C are strongly detected by anti-
K56-2 antibodies, while BC2L-A is barely detectable (Fig. 7). This
Table 1. Microcalorimetry titration data for the binding of
monosaccharides and oligosaccharides to BC2L-C and BC2L-C-
ct.
Ligand n
Kd
(mM)
-DH
(kJ/mol)
-TDS
(kJ/mol)
BC2LC-C-ct
D-Man 0.50 37.4 57.0 31.8
aMeMan 0.52 27.6 55.0 29.0
Trimannose
a 0.22 28.8 123.2 97.3
aMeHept 0.56 236 42.1 20.5
Diheptose
b 0.48 88.1 39. 2 16.0
BC2L-C
D-Man 0.57 21.8 6.1 34.5
aMeMan 0.49 18.3 73.5 46.4
Lewis Y 1.01 47.5 40.9 16.2
All measured values are averaged over at least two experiments. Standard
deviations are ,0.03 for n values and ,5% for the other ones.
atrimannose: Mana1-3(Mana1-6)Man.
bdiheptose: L,D-Hepa1-3L,D-Hep.
doi:10.1371/journal.ppat.1002238.t001
Figure 3. Glycan array data obtained with the whole BCL2-C lectin and the two domains expressed separately. Purified BC2L-C lectin
samples were labeled with Alexa Fluor and tested on Glycan Array of the Consortium for Functional Glycomics. The BC2L-C-ct and BCLC-nt domains
bind specifically to mannosylated and fucosylated oligosaccharides, respectively while the whole lectin binds to both.
doi:10.1371/journal.ppat.1002238.g003
Table 2. Data collection and refinement statistics of BC2L-C-
ct crystal structure.
native
Data collection statistics
Beamline ID14-1
Unit cell (A ˚) a=b=100.81
c=47.313
Spacegroup P65
Wavelength (A ˚) 0.934
Resolution limit (A ˚) 50.38–1.90 (2.00–1.90)*
Total observations 136740
Unique reflections 21277 (2700)
Completeness 97.5 (85.9)
Multiplicity 6.4 (2.4)
,I./,sI. 11.3 (2.8)
Rmerge (%)
b 5.3 (21.1)
Wilson B-factor (A ˚2)1 7 . 6 9
Refinement statistics
Rcryst 15.8%
Rfree 19.9%
RMSD bonds 0.015
RMSD angles 1.488
Ramachandran’s outliers 2
Protein atoms 1795
Water atoms 286
Other atoms 10
Overall B-factors
Main chains 16.6
Side chains 19.3
Water atoms 33.6
PDB code 2XR4
* Values in parenthesis refer to the highest resolution shell.
b Rmerge = g|I2,I.|/|g,I.|, Rcryst =( g||Fobs – Fcalc||)/(g||Fobs||).
doi:10.1371/journal.ppat.1002238.t002
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and -C lectins in B. cenocepacia K56-2. Since intact bacterial cells
were used in the immunisation procedure, we conclude that the
lectins are present on the cell surface.
BC2L-A, -B and -C lectins were tagged with a FLAG epitope at
their N-terminus and expressed as recombinant lectins in B.
cenocepacia K56-2. Culture supernatant analysis by Western blot
using anti-FLAG and anti-RNA polymerase alpha subunit
antibodies (used as a cell lysis control) revealed that the three
lectins are secreted or released into the extracellular medium
without detectable cell lysis (Fig. 8A).
To determine whether BC2L-A, -B and C lectins associate to the
bacterial cell surface, bacterial cells expressing the FLAG-tagged
lectins were incubated with buffer or with 50 mM D-mannose for
5 min. Western blot using anti-FLAG and anti-RNAPa revealed
that BC2L-B and -C lectins are released into the supernatant upon
incubation with mannose but not with buffer only. That BC2L-B
and -C lectins are specifically released upon mannose treatment
withoutanydetectable celllysissuggests thatBC2L-Band -C lectins
are located on the surface of B. cenocepacia (Fig. 8B).
The BC2L-C TNF-a-like N-terminal domain elicits IL-8
secretion by epithelial cells
Since the crystal structure of BC2L-C-nt demonstrated a TNF-
a-like fold [12], the immunostimulatory activities of BC2L-C and
its domains were tested on epithelial cells. A markedly increase in
IL-8 production was observed in cells exposed to BC2L-C and this
activity was attributed to the N-terminal domain (Fig. 9). Attempts
to inhibit the IL-8 production by carbohydrate ligands were
unsuccessful (data not shown), indicating that the carbohydrate-
binding and pro-inflammatory eliciting activities reside in different
parts of the molecule. Attempts to inhibit IL-8 production using
siRNA directed against the TNF-a receptor (TNFR1) also resulted
in negative results (Fig. S5). The immunostimulatory activity of
BC2L-C is therefore mediated by its N-terminal domain in a
carbohydrate-independent manner, and does not appear to be
mediated by selective binding to TNFR1.
Discussion
To our knowledge, BC2L-C is the first protein identified
harbouring two different lectin domains with distinct specificity, for
which we refer to it to as a ‘‘superlectin’’. Multispecificity was only
found in lectins with duplicated domains resulting from divergent
evolution, such as some human galectins and plant lectins [19,20].
The association of two functionally and structurally distinct domains
in BC2L-C is therefore the paradigm for a new class of lectins.
The cellular localisation of the soluble lectins produced by
opportunistic bacteria remains an open question. While the lectins
have a role in host recognition, they are present in large quantity in
the cytoplasm and do not contain any canonical secretion signals.
Previous work demonstrated the location of LecB on the outer
membrane of P. aeruginosa [21] and recent work suggested that
transient glycosylation of the lectin is required for transportation
[22]. Our data indicate that B. cenocepacia lectins are also located at
the bacterial surface. Control data monitoring the RNA polymerase
alpha subunit (cytoplasmic protein used as cell lysis control)
demonstrate that the lectin does not exit by simple cell lysis.
Therefore, the lack of typical secretion sequences in these lectins
suggests they are secreted by one or more specialized secretion
systems that are yet to be identified. We also demonstrate that
surface localisation depends on the mannose-binding site in the C-
terminal domain, since treatment of bacterial cells with D-mannose
results in the release of the lectins. Since this binding site has strong
affinity for L-D-heptose, an abundant component of the B. cenocepacia
LPS [14], it is possible that LPS may provide an attachment site on
the bacterial surface. However, attempts to demonstrate lectin
binding to LPS were unsuccessful (data not shown), suggesting that
the lectin may bind to a different bacterial surface molecule.
The unique hexameric architecture of BC2L-C is well suited for
cross-linking between bacteria and epithelial cells (Fig. 10). The
advantage of such flexible structure is that all carbohydrate
binding sites can be exposed at the surface and free to interact.
Also, a flexible linker could adapt its conformation under shear
force and provide tight binding as observed in some pili adhesins
[23]. The three mannose/heptose binding sites, responsible for
bacterial surface binding, are located in the external part of the
middle ring, while the fucose binding sites, that binds to H-type 1
and other fucosylated epitopes on glycolipids, are present at each
extremity. These TNF-a-like N-terminal domains have a strong
pro-inflammatory effect, as determined by IL-8 release by
epithelial cells. Lung infection by B. cenocepacia in CF patients is
characterized by strong inflammation [24]. In addition to the
classical activation of Toll-like receptors by LPS and flagella [25],
it has been recently demonstrated that B. cenocepacia activates the
TNFR1 signalling in cystic fibrosis airway epithelial cells [26].
In conclusion, our study opens many questions about the
biological function of super lectins in opportunistic bacteria.
Future work will unravel the binding epitope on the bacterial cell
surface and provide more details on the physiological role of the
super lectin in the infection processes.
Materials and Methods
Carbohydrate material
Monosaccharides (Sigma), trimannoside (Dextra) and Lewis Y
(Elicityl) were obtained from commercial sources. Methyl L-glycero-
a-D-manno-heptopyranoside and allyl L-glycero-a-D-manno-heptopyr-
anosyl-(1R3)-L-glycero-a-D-manno-heptopyranoside were synthe-
sized according to published procedures [27,28] that are briefly
described in Text S1.
Gene cloning and protein expression and purification
The gene encoding full-length BC2L-C was synthesized by
GenScript Corp with optimization for expression in E. coli and
contained flanking NdeI and HindIII sites. This synthetic gene was
cloned into pRSET vector (Invitrogen), resulting in pRSET_bc2l-c,
which was used as a template to clone pRSET_bc2l-c-ct encoding
BC2L-C-ct (Table S2). E. coli BL21 (DE3) cells containing plasmid
pRSET_bc2l-c and/or pRSET_bc2l-c-ct were cultured in LB broth
low salt medium (Duchefa Biochemie) containing 100 mM
ampicillin at 37uC until the OD600 reached ,0.5. After the
addition of 0.5 mM IPTG (Duchefa Biochemie), cells were
cultured for an additional 3 hours at 30uC, harvested by
centrifugation and resuspended in 20 mM Tris buffer containing
100 mM NaCl and 100 mM CaCl2, pH 7.5. Cells were disinte-
grated by ultrasonic vibration and the soluble fraction was
collected by centrifugation at 21000 g at 4uC for 30 min.
Figure 4. Crystal structure of apoBC2L-C C-terminal domain. A. Dimeric organisation of apo-BC2L-C-Ct, the protein is represented as ribbon.
The sulphate ion close to one of the calcium and monosaccharide binding site is represented as sticks. B. Open conformation of the binding site in
the absence of calcium and ligand. The sulphate ion interacts with Gln204, His177 and water molecules. C. Molecular modelling of BC2L-C-Ct in
complex with calcium and a-methyl-mannoside with rearrangement of binding amino acids. D. Model of the complex with a-methyl-heptoside.
doi:10.1371/journal.ppat.1002238.g004
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Recombinant BC2L-C and/or BC2L-C-ct were purified by
affinity chromatography on the mannose-agarose (Sigma-Aldrich)
column using an FPLC system (A ¨CTA, GE Healthcare). After
washing, specific elution was carried out with 20 mM Tris pH 7.5,
100 mM NaCl and 10 mM EDTA. The protein was dialysed in
10 mM Tris pH 7.5, 20 mM NaCl and 1 mM CaCl2. Protein
purity was assessed by SDS-PAGE (12% gel) and stained with
Coomassie Brilliant Blue R-250 (Sigma Aldrich). Preparation of
BC2L-C-nt was performed as described previously [12].
Surface plasmon resonance
SPR experiments were performed on a BIAcore 3000
instrument (GE Healthcare) at 25uC using a running buffer
HEPES - Buffered Saline (HBST) (10 mM HEPES and 150 mM
NaCl, pH 7.5 containing 0.005% (v/v) Tween 20) and a flow rate
of 5 mL per minute. Two different chips presenting monosaccha-
rides have been used. Biot-PAA (biotinylated polyacrylamide)
probes bearing sugar moieties (Lectinity Corp, Russia) were
trapped on a CM5 (BIAcore Life Science) sensor chip that was
coated with streptavidin using the standard procedure (Amine
coupling, BIAcore Sensor Surface Handbook). Each Biot-PAA-
monosaccharide (50 mL at concentration 200 mg/mL) was injected
to the selected channel. Direct binding curves of the lectin to
immobilised sugars were measured over the concentration range
0.35–0.45 mg/mL. Samples were injected (20 mL, KINJECT)
onto the CM5 chip at a flow rate 5 mL/min. The chip was
regenerated using 100 mM EDTA and 50 mM NaOH. Binding of
Figure 5. Three-dimensional reconstruction of BC2L-C. A. Refined ab-initio SAXS envelop. B. Isosurface representation of the EM
reconstruction. C. Superposition of EM reconstruction with the SAXS envelope. D. Ten projections of the EM reconstruction (upper row) are shown for
a visual comparison with the class averages (lower row).
doi:10.1371/journal.ppat.1002238.g005
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resonance units (RU) over time and data were evaluated using
the BIAevaluation Software (version 4.1).
Glycan array
Purified BC2L-C lectin samples were labeled with Alexa Fluor
488-TFP (Invitrogen, CA) according to manufacturer’s instruc-
tions and re-purified on a D-Salt polyacrylamide desalting column
(Pierce, Rockford IL). Alexa-labeled proteins were used for glycan-
array screening with standard procedure of the Core H of the
Consortium for Functional Glycomics (Emory University, Atlanta,
GA, http://www.functionalglycomics.org). The screening of the
printed glycan microarray chip (version 3.2, with 377 glycans from
a library of natural and synthetic glycans) was performed with a
concentration of BC2L-C of 200 mg/mL dissolved in 20 mM
HEPES, 140 mM NaCl, 5 mM CaCl2, pH 7.5 for all samples.
Figure 6. Models of the BC2L-C hexamer with N-terminal domains in blue and C-terminal domains in green. A. Best manual fit of the
different domains of BC2L-C hexamer in the ab-initio SAXS envelop. B. Two possible arrangements of trimers that could correspond to the manual fit.
C. Orthogonal orientations of the mode I. Linkers have been schematized by dotted lines. Calcium and carbohydrate ligands (fucose for the N-
terminus and mannose for C-terminus) are represented by spheres.
doi:10.1371/journal.ppat.1002238.g006
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Experiments were performed at 2560.1uC using VP-ITC and
ITC200 calorimeters (Microcal, GE Healthcare). Saccharides and
proteins were dissolved in the same buffer (20 mM Tris pH 7.5,
20 mM NaCl and 0.03 mM CaCl2). Protein concentration for
measurements varied from 125 to 400 mM. Aliquots of 2 or 10 mL
of sugar solution at various concentrations from 1.56 to 50.0 mM,
were added automatically to the protein solution present in the
calorimeter cell. Stirring was adjusted to at 300 and 1000 rpm.
Titration of BC2L-C and BC2L-C-ct was performed with
aMeMan, D-mannose and a-methyl-L-fucoside, trimannose and
diheptose. Control experiments performed by injections of buffer
in the protein solution yielded insignificant signals. Integrated heat
effects were analysed by non-linear regression using a single-site
binding model (Microcal Origin 7). The experimental data fitted
to a theoretical titration curve brought up the association constant
Ka and the enthalpy of binding DH. The other thermodynamic
parameters such as free energy DG and entropy DS were calculated
from the equation: DG=DH-T DS = -RTlnKa, where T is the
absolute temperature and R is molar gas constant (8.314
J.mol
21.K
21). All experiments were performed with c values
between 10, c ,100 [29]. At least two or three independent
titrations were performed for each tested ligand.
Crystallography and molecular modelling
Lyophilized BC2L-C-ct was solubilised (14.5 mg/mL) in 5 mM
Tris buffer (pH 7.5) containing 4.0 mM aMeMan and 0.1 mM
CaCl2. Initial crystallization conditions were determined using
commercial crystallization screens (Hampton Research and
Molecular Dimension Limited) using a Mosquito robot (TTP
LabTech Ltd). Protein crystals in the form of thin baguettes with
hexagonal profile appeared after several weeks at 17uC in the
presence of 100 mM Sodium Citrate pH 5.5 and 2.5 M
Ammonium Sulphate. These initial conditions were optimized
and scaled up to 4 mL hanging drops resulting in bigger crystals
with the same shape. Crystals were cryocooled at 100 K in liquid
nitrogen after soaking them for as short a time as possible in 30%
(v/v) glycerol mixed with precipitant solution. Diffraction data for
BC2L-C-ct were collected on the beamline ID14–1 at ESRF
(Grenoble) using an ADSC Q210 CCD detector (Quantum
Corp.). Diffraction images were integrated using MOSFLM [30],
scaled and converted into structure factors using the CCP4
program suite [31]. Protein crystallised in the hexagonal space
group P65 (a = b =100.814 A ˚, c=47.313 A ˚, c=120.0u) with two
monomers in the asymmetric unit. The 1.9 A ˚ structure was solved
by molecular replacement using the MOLREP program [32,33].
A monomer of CVIIL lectin (PDB: 2BV4) from Ch. violaceum [17]
was used as a search model. Crystallographic refinement was
carried out with the program REFMAC5 [34] alternated to
manual rebuilding using WinCoot [35]. The solvent model was
built automatically with the program ARP/wARP [36] and
revised manually with WinCoot. Stereochemical verification was
performed with the PROCHECK program [37]. Details about
data collection and refinement statistics are available in Table 2.
The final model for the apo-form of BC2L-C-ct was deposited in
the PDB database with accession code 2XR4. A model of the
binding site in complex with aMeMan and calcium ions was
produced combining the -apo structure from the present structure
combined with that from the complex between R. solanacearum RS-
IIL and aMeMan (pdb code 1UQX) [18]. Briefly, a monomer of
RS-IIL complexed with aMeMan was fitted on one monomer of
BC2L-C-ct and the side chains of amino acids in the binding site
of BC2L-C-ct were adjusted to match those of RS-IIL. Coor-
dinates for monosaccharide and calcium ions were merged with
those of BC2L-C-ct. Hydrogen atoms and partial charges were
added using Sybyl software (Tripos Inc, St Louis) using Amber
parameters for the protein and PIM parameters for carbohydrates
[38]. Energy minimisation was performed with geometry optimi-
sation of all hydrogen atoms, monosaccharide and side chains in
the binding site. Graphical representations are performed with
Sybyl and Pymol (Pymol.org).
Size exclusion chromatography - Multiple angle laser
light scattering (SEC-MALLS)
BC2L-C whole protein and its separate domains were analysed
on the Superdex 200 (GE Healthcare) column equilibrated with
20 mM Tris, 250 mM NaCl, 1 mM CaCl2, pH 7.5 using the
FPLC system (A ¨CTA, GE Healthcare). A 200 mL sample was
loaded at a flow rate of 0.4 mL/min. Molecular weights were
determined using gel filtration standard (Bio-Rad). Fractions
corresponding to molecular mass of hexamer, dimer and trimer,
respectively, were concentrated by centrifugation (Vivaspin,
Sartorius Stedim Biotech) up to the concentration of 4.2 mg/mL
for BC2LC, 7.5 mg/mL for BC2L-C-nt and 10.7 mg/mL for
BC2L-C-ct, respectively, and used for SEC-MALLS analysis.
100 mL of each sample was loaded at a flow rate of 0.4 mL/min.
On-line MALLS detection was performed with a DAWNEOS
detector (Wyatt Technology Corp.) using a laser emitting at
690 nm and by refractive index measurement using an RI2000
detector (Schambeck SFD). Weight-averaged molar masses (Mw)
were calculated using the ASTRA software (Wyatt Technology
Corp.).
Small angle X-ray scattering
The BC2L-C protein was purified by gel filtration (as previously
described) immediately prior to the SAXS experiment. The
central fraction of the peak containing the hexameric BC2L-C
(1.27 mg/mL) was collected and used to prepare two additional
dilutions (0.66 and 0.31 mg/mL) with sample concentrations
verified using a spectrophotometer (NanoDrop Technologies). The
rest of the fractions containing the hexameric BC2L-C were
collected and concentrated to 4.2 mg/mL. SAXS data from the
resulting samples (from 0.33 to 4.2 mg/mL) were collected at
the ESRF BioSAXS station (ID14EH3, http://www.esrf.fr/
UsersAndScience/Experiments/MX/About_our_beamlines/ID14-3)
at fixed energy wavelength (13.32 keV, l=0.931 A ˚). Samples
Figure 7. Immunodetection of soluble lectins. 10 mg of purified
lectins were separated on a 16% SDS-PAGE, and the gel stained with
Coomassie Blue or transferred to nitrocellulose membranes that were
reacted with anti-cepacia polyclonal rabbit antibodies. Reacting bands
were detected by fluorescence with an Odyssey infrared imaging
system (Li-cor Biosciences) using IRDye800CW affinity purified anti-
rabbit IgG antibodies (Rockland, Pennsylvania). M, prestained molecular
weight standards. The star indicates the presence of a weak bank for
Bcl2L-A.
doi:10.1371/journal.ppat.1002238.g007
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quartz capillary mounted in vacuum using an automated robotic
system (developed as part of a trilateral collaboration between
ESRF and EMBL Hamburg and Grenoble Outstation) which
enables the sample to pass through the beam during exposure to
minimise the effect of radiation damage. 2D scattering images
were collected on a Pilatus 1M detector (Dectris) 1.83 m from the
sample. Standard data collection was used for all data (10 frames
each 10 second in duration). Individual time frames are processed
automatically and independently by the data collection software
(BsxCUBE) developed at the ESRF, yielding individual radially
averaged curves of normalised intensity versus scattering angle
(s=4pSinh/l in nm). Time frames are combined excluding any
data points affected by aggregation induced by radiation damage
to give the average scattering curve for each measurement. The
scattering from the buffer alone was measured before and after
each sample measurement and the average of the scattering before
and after each sample was used for background subtraction, the
different concentrations were then compared and merged to
obtain the idealized scattering curve using the program PRIMUS
(13) form the ATSAS package developed by EMBL Hamburg.
Ab-initio models were produced with DAMMIF (14) and averaged
with DAMAVER [39]. Rigid body modeling was undertaken
using MASHA [40] with 6 additional random chains of 28
residues created by ranch13 (also part of the ATSAS package from
EMBL-Hamburg) to represent the linkers. The plot of the fits was
produced with the beta version of SASPLOT from the upcoming
cross-platform release of the ATSAS package developed at EMBL-
Hamburg.
Electron microscopy
For preparation of negatively stained BC2L-C, the purified
sample was diluted to 0.05 mg/mL, applied to the clear side of
carbon on a carbon-mica interface and stained with 2% (w/v)
sodium silicotungstate at pH 7. Images were recorded under low-
dose conditions with a JEOL 1200 EX II microscope at 100 kV
and at nominal 400006 magnification. Selected negatives were
digitized on a Zeiss scanner (Photoscan TD) at a step size of 14
micrometer giving a pixel size of 3.5 A ˚ at the specimen level. A
generous semi-automatic particle selection with the EMAN boxer
Figure 8. Localisation of B. cenocepacia soluble lectins in bacterial cells. A. BC2L-A, -B and –C are secreted into the growth medium. Analysis
of concentrated culture supernatants and total cell lysates recovered from B. cenocepacia K56-2 containing the control plasmid pEL-1 (lanes 1 and 5),
K56-2 pBC2L-A-FLAG (lanes 2 and 6), K56-2 pBC2L-B-FLAG (lanes 3 and 7) and K56-2 pBC2L-C-FLAG (lanes 4 and 8). B. BC2L-B and –C are released from the
bacterial surface upon mannose treatment. Analysis of concentrated supernatants from cells treated with PBS or 50 mM D-mannose and total cell
lysates recovered from B. cenocepacia K56-2 pBC2L-A-FLAG (lanes 1), K56-2 pBC2L-B-FLAG (lanes 2) and K56-2 pBC2L-C-FLAG (lanes 3). Western blots were
performed using anti-FLAG and anti-RNAP alpha subunit antibodies (cell lysis control). A degradation product from BC2L-C can be detected in the
total cell lysates. The arrow highlights the position of the RNAP alpha subunit in total cell extracts. Samples were boiled 10 min prior to loading on
18% SDS-PAGE gels.
doi:10.1371/journal.ppat.1002238.g008
Super Lectin from Burkholderia cenocepacia
PLoS Pathogens | www.plospathogens.org 11 September 2011 | Volume 7 | Issue 9 | e1002238routine [41] lead to an extraction of a total of 18426 subframes of
56656 pixels containing individual BC2L-C complex particle
frames which were CTF-corrected with CTFFIND3 [42] and
bsoft [43], and low-path-filtered at 15 A ˚ with Imagic-5. Subse-
quent data processing was performed with the Imagic-5 software
package [44]. The data set was translationally but not rotationally
aligned relative to the rotationally averaged total sum of the
individual images. This translationally centered data set was
subjected to multivariate statistical analysis and classification.
Characteristic class averages were then used as a set of references
for multireference alignment of each subframe with Spider [45,46]
and the new translational parameters were used to update the
boxer coordinates and extract better centered particles. This
procedure was repeated several times until the classes became
stable and the individual frames well centered. At this point, the
class averages were compared to projections of the current SAXS
model of BC2L-C filtered to 25 A ˚ resolution. Given a notable
similarity between them, the SAXS model was filtered to 80 A ˚
resolution in order to resemble a nearly featureless blob of density
but conserve the particle dimensions. This blob was used as an
initial model for iterative projection matching with Spider [45,46].
The resolution of the final 3D reconstruction of the negatively
stained BC2L-C was estimated via Fourier shell correlation to be
around 20 A ˚ according to the conservative 0.5 criterium.
Production of FLAG-tagged lectins in B. cenocepacia
The epitope FLAG-containing sequence was excised from
plasmid pBADNTF [47] and subcloned into pDA12 [48] using
EcoRI and HindIII restriction enzymes, giving rise to pEL-1. The
lectin encoding genes (BCAM0184 (bc2l-b), BCAM0185 (bc2l-c) and
BCAM0186 (bc2l-a)) were PCR amplified by use of B. cenocepacia
J2315 genomic DNA as template and sense and antisense primers
with BamHI and HindIII restriction sites, respectively that were
designed for each gene. Primer pairs were as follows: (59TTTAG-
GATCCTGCTGATTCTCAAACGTCATCCA-39) and (59-TT-
TTAAGCTTAACGTG CGTCAGGTCAGC-39) for bc2l-a;( 5 9-
TTTTGGATCCTTCACAACCCTTTACCCACGA-39) and (59-
TTTTAAGCTTGTGATGTAACGGCGAAGACC-39) for bc2l-
b;( 5 9-TTTTGGATCCTC CCCTCCTTTCGGCTTCGAT-39)
and (59-TTTTAAGCTTGTACAGCAGTGGGACTGCAA-39)
for bc2l-c. Amplicons were digested with BamHI and HindIII
and ligated into similarly digested pEL-1 giving rise to pBC2L-
AFLAG, pBC2L-BFLAG and pBC2L-CFLAG plasmids, which encode
BC2L-A, BC2L-B and BC2L-C, respectively N-terminally fused to
the FLAG epitope. Plasmids were mobilized into B. cenocepacia
K56-2 by triparental mating using E. coli DH5a carrying the
helper plasmid pRK2013 [49] as previously described. Exconju-
gants were selected onto tetracycline 100 mg/ml and gentamicin
50 mg/mL containing plates.
Preparation of culture supernatant proteins and western
blot analysis
Culture supernatant proteins were precipitated with trichlor-
oacetic acid as described previously [48] The protein concentra-
tion was determined by Bradford assay (Bio-Rad) and 4 mgo f
protein were loaded on a 18% SDS-PAGE gel. After electropho-
resis, gels were transferred to nitrocellulose membranes for
immunoblot analysis. The membranes were incubated with the
4RA2 monoclonal antibody (Neoclone) cross-reacting with the B.
cenocepacia RNA polymerase subunit alpha (cytosolic protein, cell
lysis control) and the FLAG M2 monoclonal antibody (Sigma).
The Alexa Fluor 680 goat anti-mouse IgG (Molecular Probes) was
used as a secondary antibody. Detection was performed using the
Odyssey Infrared Imager (LI-COR Biosciences).
Mannose-dependent lectin extraction
Overnight cultures were diluted to an OD600 nm of 0.03 in
50 mL LB and grown at 37uC for 8 h. Cells were then centrifuged
at 5000 g for 10 min. The pellet was washed twice with 25 mL of
phosphate buffered saline (PBS) and finally resuspended in 1.5 mL
PBS. Five hundred mL aliquots were placed into two eppendorf
tubes to which 500 mL of PBS or 500 mL of 100 mM D-mannose
made in PBS (50 mM final concentration) was added. Samples
were gently mixed by inversion and incubated for 5 min at room
temperature. Samples were centrifuged at 6000 g for 5 min,
supernatants were collected (800 mL) and filter-sterilized using
0.2 mM filters. Proteins were precipitated overnight at 4uC with
trichloroacetic acid (10% final concentration). Samples were
centrifuged at 16 000 g for 30 min at 4uC. Each pellet was then
washed with 1 mL of ice-cold acetone, air-dried and resuspended
in 15 mL of sodium phosphate buffer 0.1 M pH 7.2. The totality
of the samples were loaded on a 18% SDS-PAGE gel.
Figure 9. Activation of respiratory epithelial cells by BC2L-C
and its separate domains. Sub-confluent BEAS-2B cells cultured in
24-well plates were incubated in 300 mL medium with either BC2L-C,
BC2L-C-nt or BC2L-C-ct at 0.3 mM. As negative and positive controls,
cells were either not stimulated (NS), incubated with the suspension
buffer of BC2L-C (buffer) or challenged with 10 ng/mL of TNF-a (TNF).
After 15 h, supernatants were collected and IL-8 concentrations were
measured by ELISA. Each histogram is the mean 6 sem of 3
experiments performed in triplicate.
doi:10.1371/journal.ppat.1002238.g009
Figure 10. Schematic representation of BC2L-C hexamer cross-
linking host epithelial cells and bacteria surface.
doi:10.1371/journal.ppat.1002238.g010
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BC2L-C and its separate domains were used for the stimulation
of the human bronchial cell line BEAS-2B obtained from the
American Type Cell Collection (Manassas, VA). Cells were
maintained in serial passage in F-12K culture medium supple-
mented with 10% FCS, 1% penicillin and streptomycin, 1%
glutamine and 10 mM HEPES in 75 cm2 culture flasks and
seeded at 5610
4 on 24-well plates 3 days before stimulation. In all
experiments, BEAS-2B cells were stimulated during 15 hours with
the different agonists in a 300 mL medium. IL-8 concentrations in
cell culture supernatants were determined using a Duo-Set ELISA
kit. Duo-Set ELISA kit and the recombinant human TNF-a were
obtained from R&D Systems (Minneapolis, MN).
Supporting Information
Figure S1 Microcalorimetry data. (A) ITC plot (measured
by VP-ITC, Microcal) obtained from the titration of Met-a-Man
(3.036 mM) to BC2L-C-ct domain (386 mM). (B) ITC plot
(measured by ITC200, Microcal) obtained from the titration of
Trimannoside (2.937 mM) to BC2L-C-ct (510 mM). (C) ITC plot
(measured by ITC200, Microcal) obtained from the titration of
diheptose (2.1 mM) to BC2L-C-ct (350 mM). Protein and
saccharide were prepared in 20 mM Tris pH 7.5, 100 mM NaCl
and 5 mM CaCl2. Temperature 25uC was adjusted. The lower
plots show the total head released as a function of total ligand
concentration for the titration shown in panel up. The solid line
represents the best least-square fit for the experimental data.
(DOCX)
Figure S2 SEC-MALLSdata. Size exclusion chromatogram
combined with MALLS molecular mass evaluation of the whole
protein BC2L-C (black curves), N-terminal domain (blue curves)
and C-terminal domain (red curves). Short curves represent the
molecular mass variation across the chromatographic peak.
(DOCX)
Figure S3 Guinier analysis. Calculated Guinier regions
(straight lines) are overlaid on the experimental data points for
the four datasets.
(DOCX)
Figure S4 Fit to the SAXS data. Blue dots: experimental data
collected at ESRF bioSAXS beamline ID14-3, Error bars in Grey
calculated from Poisson counting statistics. Green line: theoretical
scattering from model with 6 linkers (28 residues each) added to
the fixed domains positioned using the EM and SAXS derived
envelope. The overall size and shape of the model match the
experimental data well. The fit is not ideal as seen by the chi of 3.5
and the systematic deviation at 0.2 A ˚ -1 which are caused by the
flexibility of the protein in solution which cannot be fully
accounted for in the rigid model.
(DOCX)
Figure S5 Lack of inhibition of siRNA anti TNFR1A on
the activation of respiratory epithelial cells by BC2L-C-
Nter domain. Small interfering RNA (siRNA)s directed against
TNFR1A and TNFR1B (ON-TARGET plus SMART pool) were
obtained from Dharmacon Inc. (Chicago, IL). siRNAs were
transfected into BEAS-2B cells using Lipofectamine
TM 2000
transfection reagent (Invitrogen) according to the manufacturer’s
instructions. Briefly, cells were seeded with 36104 cells per well
(24-well plates) in 1 mL of complete F12K (containing 10% FCS
and antibiotics) 24 h prior to transfection. For transfection and per
well, 20 nM siRNA were incubated for 20 min in 0.75 mLo f
Lipofectamine
TM 2000 diluted in 50 mL of FCS and antibiotic-free
F12K (Invitrogen). This lipofectamine/siRNA solution was mixed
with 250 mL of FCS and antibiotic-free F12K, added to the cells
and incubated for 8 h. The medium was replaced with 1 mL of
complete F12K and the cells were used after 48 h. Sub-confluent
BEAS-2B cells cultured in 24-well plates were incubated in 300 mL
medium with BC2L-C-nt at either 0.1 mM or 0.3 mM. As negative
and positive controls, cells were either not stimulated (NS) or
challenged with 10 ng/mL of TNF-a (TNF). After 15 h,
supernatants were collected and IL-8 concentrations were
measured by ELISA. Each histogram is the mean 6 sem of 3
experiments performed in triplicate.
(DOCX)
Table S1 Concentration dependence of Rg and I0.
(calculated using AutoRg with variance estimated altering the
data points used within the Guinier region). Merged data are
obtained with the program PRIMUS by merging the low-angle
region of the 1.27 mg/ml dataset (as the 0.66 and 0.31 mg/mL
datasets showed variation in Rg of approximately 0.2 nm due to
low signal-to-noise ratio) with the high-angle region of the 4.20
mg/mL dataset.
(DOCX)
Table S2 Characteristics of the recombinant BC2L-C
lectin and its domains.
(DOCX)
Text S1 Procedures for synthesis of methyl L-glycero-
a-D-manno-heptopyranoside and allyl L-glycero-a-D-
manno-heptopyranosyl-(1R3)-L-glycero-a-D-manno-
heptopyranoside.
(DOCX)
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